Nove Mesto

Slovakia

7 total trials

Filter these 7 trials by phase, condition, sponsor and more.

Open in Search →

Study to Evaluate Plozasiran in Adults with Severe Hypertriglyceridemia (SHASTA-4 Study) Ended recruitment

2023-509301-80-00 5 2024-11-04 Severe hypertriglyceridemia (SHTG)
Study to Evaluate Plozasiran in Adults with Hypertriglyceridemia (MUIR-3 Study) Ended recruitment

2023-509302-30-00 5 2024-11-04 Hypertriglyceridemia
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended recruitment

2022-501419-15-00 5 2023-08-23 Atrial Fibrillation
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients with Stable Angina (ORESA Study) Halted

2024-512313-41-00 5 2025-05-19 Stable Angina Pectoris
A Study to Evaluate the Effects of Various Degrees of Hepatic Impairment on the Pharmacokinetics of A Single Subcutaneous Dose Of RO7434656, … Ended

2023-508270-29-01 3 2024-09-24 Hepatic Impairment
A Study About Fazirsiran in People With and Without Liver Problems. Ended

2023-503735-17-00 3 2023-10-05 Hepatic impairment.
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Camizestrant in Post-menopausal … Ended

2022-502277-41-00 3 2023-06-05 moderate or severe hepatic impairment

Showing 1–7 of 7 trials